MARC details
000 -LEADER |
fixed length control field |
05407cam a2200613 i 4500 |
001 - CONTROL NUMBER |
control field |
ocn872568714 |
003 - CONTROL NUMBER IDENTIFIER |
control field |
OCoLC |
005 - DATE AND TIME OF LATEST TRANSACTION |
control field |
20240729131529.0 |
006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS--GENERAL INFORMATION |
fixed length control field |
m d |
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION |
fixed length control field |
cr ||||||||||| |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
fixed length control field |
130703s2013 nyu ob 001 0 eng |
010 ## - LIBRARY OF CONGRESS CONTROL NUMBER |
LC control number |
2019713842 |
040 ## - CATALOGING SOURCE |
Original cataloging agency |
DLC |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
ISBN |
9781628085242 |
Qualifying information |
ebook |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
ISBN |
162808524X |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
Cancelled/invalid ISBN |
9781628085075 |
Qualifying information |
hardcover |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
Cancelled/invalid ISBN |
162808507X |
035 ## - SYSTEM CONTROL NUMBER |
System control number |
710361 |
-- |
(N$T) |
035 ## - SYSTEM CONTROL NUMBER |
System control number |
(OCoLC)872568714 |
042 ## - AUTHENTICATION CODE |
Authentication code |
pcc |
072 #7 - SUBJECT CATEGORY CODE |
Subject category code |
HEA |
Subject category code subdivision |
039000 |
Source |
bisacsh |
072 #7 - SUBJECT CATEGORY CODE |
Subject category code |
MED |
Subject category code subdivision |
014000 |
Source |
bisacsh |
072 #7 - SUBJECT CATEGORY CODE |
Subject category code |
MED |
Subject category code subdivision |
022000 |
Source |
bisacsh |
072 #7 - SUBJECT CATEGORY CODE |
Subject category code |
MED |
Subject category code subdivision |
112000 |
Source |
bisacsh |
072 #7 - SUBJECT CATEGORY CODE |
Subject category code |
MED |
Subject category code subdivision |
045000 |
Source |
bisacsh |
049 ## - LOCAL HOLDINGS (OCLC) |
Holding library |
MAIN |
245 00 - TITLE STATEMENT |
Title |
Liver failure : |
Subtitle |
etiologies, neurological complications and emerging therapies |
Statement of responsibility, etc |
|
Medium |
[E-Book] |
264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE |
Place of production, publication, distribution, manufacture |
New York : |
Name of producer, publisher, distributor, manufacturer |
Nova Biomedical, |
Date of production, publication, distribution, manufacture, or copyright notice |
[2013] |
300 ## - PHYSICAL DESCRIPTION |
Physical description |
1 online resource. |
336 ## - CONTENT TYPE |
Content type term |
text |
Content type code |
txt |
Source |
rdacontent |
337 ## - MEDIA TYPE |
Media type term |
computer |
Media type code |
c |
Source |
rdamedia |
338 ## - CARRIER TYPE |
Carrier type term |
online resource |
Carrier type code |
cr |
Source |
rdacarrier |
490 1# - SERIES TITLE |
Series statement |
Hepatology research and clinical developments |
504 ## - BIBLIOGRAPHY, ETC. NOTE |
Bibliography, etc |
Includes bibliographical references and index. |
505 0# - CONTENTS |
Contents |
LIVER FAILURE: ETIOLOGIES, NEUROLOGICAL COMPLICATIONS AND EMERGING THERAPIES; Library of Congress Cataloging-in-Publication Data; Contents; Preface; Section One; Chapter 1: Hepatic Failure as an Early Complication Following Orthotopic Liver Transplantation; Abstract; Introduction; Primary Complications; Vascular Complications; Immunological Complications; Biliary Complications; Team Experience of Early Post-OLT Complications; Conclusion; References; Chapter 2: Neurological Complications in Liver Transplantation; Abstract; Introduction; Communication Pathways between the Liver and the Brain. |
505 8# - CONTENTS |
Contents |
Neurological Complications Associated with Liver TransplantationMajor Neurological Complications after OLT; Immunosuppression Toxicity; Encephalopathy; Seizures; Central Nervous System Infections; Central Pontine Myelinolisis; Cerebrovascular Complications; Neuromuscular Disorders; Minor Neurological Complications after OLT; Differences in Neurological Complications Depend on the Type of Allograft; Neurological Complications in Different Transplant Centers; Conclusion; Acknowledgment; References; Chapter 3: Hepatic Encephalopathy, Cerebral Blood Flow and the Changes in Oxidative Metabolism. |
505 8# - CONTENTS |
Contents |
AbstractIntroduction; Liver Failure, Cerebral Blood Flow and Autoregulation; Ammonia and Direct Effects on Cerebral Oxidative Metabolism; Cerebral Amino Acid Transport and Metabolism; Therapeutical Implications and Future Targets; Conclusion; References; Chapter 4: New Insight into the Molecular Roles in the Pathogenesis of HepaticEncephalopathy; Abstract; Introduction; Neurobiology of Liver Failure and Hyperammonemia; Possible Cellular and Molecular Mechanism of HE; Therapeutic Target for Hepatic Encephalopathy; In Vivo and In Vitro Models for Study of Chronic Liver Impairment. |
505 8# - CONTENTS |
Contents |
Conclusion and Future DirectionsReferences; Chapter 5: Disordered Central Neural Regulation of the Cardiovascular Systemin Liver Failure; Abstract; Introduction; Brainstem/Hypothalamic Neuronal Activation in Liver Disease; Neural Activation and Portal Hypertension: Chicken or Egg?; Conclusion and Future Perspectives; References; Chapter 6: Hepatic Microcirculation in Chronic Liver Disease; Abstract; References; Chapter 7: Astrocytes and Endothelial Cells Behavior Found in Brain Hippocampus in Prehepatic Portal Hypertensive Rats; Abstract; Introduction; Portal Hypertension; The Hippocampus. |
505 8# - CONTENTS |
Contents |
Glial CellsEndothelial Cells; Hepatic Encephalopathy; Material and Methods; Results; Discussion; References; Section Two; Chapter 8: Direct Antiviral Agents for Chronic Viral Hepatitis Treatment; Abstract; Introduction; Direct Antiviral Agents for Chronic B Hepatitis Treatment; New Antiviral Drugs for Chronic Hepatits C Treatment; Conclusion; References; Chapter 9: Emergent Therapies in Acute Liver Failure; Abstract; Introduction; Auxiliary Liver Transplantation (ALT); Extracorporeal Liver Assist Devices; Hepatocyte Transplantation; New Perspectives; Acknowledgments; References. |
520 ## - ABSTRACT |
Abstract |
The recently published article ""The Burden of Liver Disease in Europe: A Review of Available Epidemiological Data"" provides a few figures on the enormous problem that liver disease poses for Europeans. Liver disease is estimated to cause 170,000 deaths annually in Europe, 47,000 of which are attributed to liver cancer; 0.5%-0.7% of the European population is affected by chronic hepatitis B; and prevalence rates of hepatitis C virus (HCV) infection in the last decade in the European population ranged from 0.13 to 3.26%. These HCV-infected populations will develop complications in the years to. |
590 ## - LOCAL NOTE (RLIN) |
Local note |
Master record variable field(s) change: 050, 082 |
650 #0 - SUBJECT HEADINGS |
Subject term |
Liver |
General subdivision |
Failure. |
650 #0 - SUBJECT HEADINGS |
Subject term |
Liver |
General subdivision |
Failure |
-- |
Treatment. |
650 #0 - SUBJECT HEADINGS |
Subject term |
Liver |
General subdivision |
Diseases. |
650 #0 - SUBJECT HEADINGS |
Subject term |
Biliary tract |
General subdivision |
Diseases. |
700 1# - ADDED PERSONAL NAME |
Added personal author |
Peralta, Carmen, |
Relator term |
editor. |
700 1# - ADDED PERSONAL NAME |
Added personal author |
Fontana, Luis, |
Relator term |
editor. |
830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE |
Uniform title |
Hepatology research and clinical developments series. |
856 ## - ONLINE RESOURCE |
Uniform Resource Identifier |
<a href="#gotoholdings">#gotoholdings</a> |
Link text |
Access resource |
942 ## - ADDED ENTRY ELEMENTS (KOHA) |
Suppress in OPAC |
Do not Suppress in OPAC |
588 ## - SOURCE OF DESCRIPTION NOTE |
Source of description note |
Description based on print version record. |
938 ## - |
-- |
EBSCOhost |
-- |
EBSC |
-- |
710361 |
994 ## - |
-- |
92 |
-- |
N$T |